康龙化成（北京）新药技术股份有限公司（股票代码：03759）于2026年7月22日发布公告，披露当日将公司约5,396,470股库存股份（占调整前已发行股本的1.53%）转让予受托人，用于已采纳的2025年H股奖励信托计划所授出的股份奖励归属之准备。转让价格为每股0港元。
该次变动完成后，公司已发行股本（不含库存股份）增至358,111,057股，库存股份数则相应降至1,866,830股，总发行股份数仍为359,977,887股。公司表示，该转让事宜已获董事会正式授权并已遵循香港联合交易所有限公司证券上市规则及有关法律法规的要求。公告由公司秘书麦宝文签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.